EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 218 | +22.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 178 | -99.8% | 0.00% | – |
| Q1 2020 | $84,000 | +171.0% | 82,049 | +302.5% | 0.00% | – |
| Q4 2019 | $31,000 | -16.2% | 20,384 | +0.4% | 0.00% | – |
| Q3 2019 | $37,000 | +32.1% | 20,295 | +19.4% | 0.00% | – |
| Q2 2019 | $28,000 | -94.5% | 17,003 | -88.2% | 0.00% | – |
| Q3 2018 | $513,000 | -34.3% | 143,565 | -61.8% | 0.00% | – |
| Q2 2018 | $781,000 | – | 375,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $21,793,000 | 11.58% |
| Kore Private Wealth LLC | 202,366 | $105,000 | 0.02% |
| BARD ASSOCIATES INC | 335,750 | $175,000 | 0.02% |
| HighTower Advisors, LLC | 5,284,688 | $2,738,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 126,529 | $66,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 654,200 | $339,000 | 0.01% |
| Virtu Financial LLC | 57,076 | $30,000 | 0.01% |
| WEDBUSH SECURITIES INC | 81,500 | $42,000 | 0.00% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 33,933 | $18,000 | 0.00% |
| MATRIX ASSET ADVISORS INC/NY | 39,500 | $20,000 | 0.00% |